Australia Dialysis Market Size and Share

Name: Australia Dialysis Market Size and Share | Statistics - 2030
Creator: Supradip Baul
Published: Jul 2025

Download Now

Australia Dialysis Market by Modality (Hemodialysis (HD), and Peritoneal Dialysis (PD)), and by End User (Hospitals, Dialysis Centers, Homecare, and Ambulatory Surgical Centers) – Global Opportunity Analysis and Industry Forecast, 2024–2030

Download PDF

Speak to Our Analyst

Market Overview:

The Australia Dialysis Market size was valued at USD 0.60 billion in 2023, and is expected to reach USD 0.84 billion by 2030, with a CAGR of 4.9% from 2024 to 2030.

Australia dialysis market is a segment of the healthcare sector focused on providing artificial kidney functions to individuals with impaired renal function. Dialysis is a life-sustaining medical procedure used to manage patients with end-stage renal disease (ESRD) or acute kidney injuries.

This market includes various products and services such as hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. Given the growing prevalence of kidney-related disorders and the increasing aging population, the market is crucial in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.

Rising Prevalence of Diabetes Boosts Demand for Dialysis Services in Australia

The growing incidence of diabetes across Australia is significantly contributing to the expansion of the dialysis market. As diabetes is a major risk factor for developing chronic kidney disease (CKD), an increasing number of patients are progressing to end-stage renal disease, which necessitates ongoing dialysis treatment. This trend is intensifying the demand for both hemodialysis and peritoneal dialysis solutions, prompting healthcare providers to enhance renal care infrastructure and adopt advanced dialysis technologies to improve patient outcomes.

Growing Aging Population Accelerates the Need for Dialysis in Australia

Australia steadily aging population is another key driver of dialysis market growth. Older adults are more susceptible to conditions such as hypertension and diabetes, which are leading causes of kidney failure. As a result, there is a rising need for long-term renal care among the elderly. This demographic shift is compelling healthcare providers to scale up dialysis services and tailor treatment offerings to address the complex medical needs of the aging population, thereby fostering market development.

Shortage of Skilled Healthcare Professionals’ Limits Market Expansion

The Australia dialysis market faces significant constraints due to a persistent shortage of skilled healthcare professionals, particularly nephrologists and dialysis-trained nurses. This shortfall directly affects the capacity of healthcare facilities to deliver timely and effective dialysis services. As the patient population requiring dialysis continues to grow, the limited availability of trained personnel contributes to increased wait times, reduced operational efficiency, and compromised quality of care. These workforce limitations hinder the scalability of dialysis services across the country, ultimately restricting the overall growth of the market.

Advancements in Dialysis Technology Create Ample Opportunity for Growth in the Australia Dialysis Market

The Australia dialysis market is witnessing significant opportunity driven by continuous advancements in dialysis technology, particularly the development of portable and home-based dialysis systems. These cutting-edge innovations are reshaping patient care by enabling treatment beyond traditional clinical settings—empowering patients to undergo dialysis from the comfort of their homes or while maintaining daily routines. This shift not only enhances patient convenience and quality of life but also helps reduce pressure on healthcare facilities. Additionally, the integration of remote monitoring and user-friendly interfaces allows healthcare professionals in Australia to efficiently track patient health and adjust treatments in real time without frequent in-person consultations. As the demand for flexible, patient-centric care models grows across the country, the evolution of advanced dialysis technologies is poised to unlock substantial growth opportunities for providers and manufacturers within the Australia dialysis market.

Competitive Landscape

Several market players operating in the Australia dialysis market include Fresenius Medical Care AG And Co. KGaA, Baxter International Inc., B Braun, Nipro Australia, Asahi Kasei Corporation, Becton, Dickinson and Company, Teleflex Incorporated, Merit Medical Systems, Tek Equipment, ITL BioMedical, and others.

Australia Dialysis Market Key Segments

By Modality

Hemodialysis (HD)
- Hemodialysis Machines
  - In-center HD
  - Home HD
- Water Treatment Systems
  - Central water-disinfection units
  - Point-of-use/portable systems
- Ancillary/Other HD Equipment
  - UF/ultrafiltration pumps
  - Dialysis chairs/beds
  - Disinfection/sterilization units
  - Monitoring & data-capture hardware
- HD Consumables & Supplies
  - Dialyzers
  - Bloodlines & Tubing Sets
  - Dialysis Fluids / Concentrates
  - Vascular Access Products
  - Other HD Consumables & Accessories
- HD Aftermarket Services
  - Repair & Maintenance
  - Installation & Commissioning
  - Training & Technical Support
Peritoneal Dialysis (PD)
- PD Cyclers / Automated PD Machines
- Ancillary PD Equipment
- PD Consumables & Supplies
  - PD Dialysis Solutions
  - PD Catheters & Access Systems
  - Transfer Sets & Tubing
  - Other PD Supplies / Accessories
- PD Aftermarket Services
  - Repair & Maintenance (Cyclers & Heaters)
  - Installation & Commissioning
  - Training & Technical Support

By End-User

Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers

Key Players

Fresenius Medical Care AG And Co. KGaA
Baxter International Inc.
B Braun
Nipro Australia
Asahi Kasei Corporation
Becton, Dickinson and Company
Teleflex Incorporated
Merit Medical Systems
Tek Equipment
ITL BioMedical

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2023	USD 0.60 Billion
Revenue Forecast in 2030	USD 0.84 Billion
Growth Rate	CAGR of 4.9% from 2024 to 2030
Analysis Period	2023–2030
Base Year Considered	2023
Forecast Period	2024–2030
Market Size Estimation	Billion (USD)
Growth Factors	Rising Prevalence of Diabetes Boosts Demand for Dialysis Services in Australia Growing Aging Population Accelerates the Need for Dialysis in Australia
Companies Profiled	10
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

1. 1.1. REPORT DESCRIPTION
2. 1.2. WHO SHOULD READ THIS REPORT
3. 1.3. KEY MARKET SEGMENTS
4. 1.4. KEY MARKET PLAYERS
5. 1.5. RESEARCH METHODOLOGY
6. 1. 1.5.1 MARKET SIZE ESTIMATION METHODOLOGY
  2. 1. 1.5.1.1 TOP-DOWN AND BOTTOM-UP APPROACH
    2. 1.5.1.2 REVENUE BREAKDOWN OF TOP 10 COMPANIES IN AUSTRALIA DIALYSIS MARKET (2024)
    3. 1.5.1.3 DEMAND AND SUPPLY-SIDE ANALYSIS
    4. 1.5.1.4 MACRO-INDICATOR APPROACH
  3. 1.5.2 DATA COLLECTION APPROACH
  4. 1. 1.5.2.1 PRIMARY DATA COLLECTION
    2. 1.5.2.2 SECONDARY DATA COLLECTION
    3. 1. 1.5.2.2.1 SECONDARY DATA SOURCES
  5. 1.5.3 FORECASTING

1. 2.1. DEFINITION

1. 3.1. MARKET SNAPSHOT, 2024 - 2030, MILLION USD

1. 4.1. MARKET DYNAMICS
2. 1. 4.1.1 DRIVERS
  2. 1. 4.1.1.1 RISING PREVALENCE OF DIABETES BOOSTS DEMAND FOR DIALYSIS SERVICES IN AUSTRALIA
    2. 4.1.1.2 GROWING AGING POPULATION ACCELERATES THE NEED FOR DIALYSIS IN AUSTRALIA
  3. 4.1.2 RESTRAINTS
  4. 1. 4.1.2.1 SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS’ LIMITS MARKET EXPANSION
  5. 4.1.3 OPPORTUNITIES
  6. 1. 4.1.3.1 ADVANCEMENTS IN DIALYSIS TECHNOLOGY CREATE AMPLE OPPORTUNITY FOR GROWTH IN THE AUSTRALIA DIALYSIS MARKET

1. 5.1. MARKET SHARE ANALYSIS OF TOP 10 AUSTRALIA DIALYSIS PROVIDERS, 2024

1. 6.1 OVERVIEW
2. 6.2 HEMODIALYSIS (HD) MARKET
3. 1. 6.2.1 HEMODIALYSIS MACHINES
  2. 1. 6.2.1.1 IN-CENTER HD
    2. 6.2.1.2 HOME HD
  3. 6.2.2 WATER TREATMENT SYSTEMS
  4. 1. 6.2.2.1 CENTRAL WATER-DISINFECTION UNITS
    2. 6.2.2.2 POINT-OF-USE/PORTABLE SYSTEMS
  5. 6.2.3 ANCILLARY/OTHER HD EQUIPMENT
  6. 1. 6.2.3.1 UF/ULTRAFILTRATION PUMPS
    2. 6.2.3.2 DIALYSIS CHAIRS/BEDS
    3. 6.2.3.3 DISINFECTION/STERILIZATION UNITS
    4. 6.2.3.4 MONITORING & DATA-CAPTURE HARDWARE
  7. 6.2.4 HD CONSUMABLES AND SUPPLIES
  8. 1. 6.2.4.1 DIALYZERS
    2. 6.2.4.2 BLOODLINES & TUBING SETS
    3. 6.2.4.3 DIALYSIS FLUIDS / CONCENTRATES
    4. 6.2.4.4 VASCULAR ACCESS PRODUCTS
    5. 6.2.4.5 OTHER HD CONSUMABLES & ACCESSORIES
  9. 6.2.5 HD AFTERMARKET SERVICES
  10. 1. 6.2.5.1 REPAIR & MAINTENANCE
    2. 6.2.5.2 INSTALLATION & COMMISSIONING
    3. 6.2.5.3 TRAINING & TECHNICAL SUPPORT
4. 6.3 PERITONEAL DIALYSIS (PD) MARKET
5. 1. 6.3.1 PD CYCLERS / AUTOMATED PD MACHINES
  2. 6.3.2 ANCILLARY PD EQUIPMENT
  3. 6.3.3 PD CONSUMABLES AND SUPPLIES
  4. 1. 6.3.3.1 PD DIALYSIS SOLUTIONS
    2. 6.3.3.2 PD CATHETERS & ACCESS SYSTEMS
    3. 6.3.3.3 TRANSFER SETS & TUBING
    4. 6.3.3.4 OTHER PD SUPPLIES / ACCESSORIES
  5. 6.3.4 PD AFTERMARKET SERVICES
  6. 1. 6.3.4.1 REPAIR & MAINTENANCE (CYCLERS & HEATERS)
    2. 6.3.4.2 INSTALLATION & COMMISSIONING
    3. 6.3.4.3 TRAINING & TECHNICAL SUPPORT

1. 7.1 OVERVIEW
2. 7.2 HOSPITALS MARKET
3. 7.3 DIALYSIS CENTERS MARKET
4. 7.4 HOMECARE MARKET
5. 7.5 AMBULATORY SURGICAL CENTERS MARKET

1. 8.1 FRESENIUS MEDICAL CARE AG AND CO. KGAA
2. 1. 8.1.1 COMPANY OVERVIEW
  2. 8.1.2 COMPANY SNAPSHOT
  3. 8.1.3 OPERATING BUSINESS SEGMENTS
  4. 8.1.4 PRODUCT PORTFOLIO
  5. 8.1.5 BUSINESS PERFORMANCE
  6. 8.1.6 BUSINESS SEGMENTS
  7. 8.1.7 GEOGRAPHIC SEGMENTS
  8. 8.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.1.9 PRIMARY MARKET COMPETITORS
3. 8.2 BAXTER INTERNATIONAL INC.
4. 1. 8.2.1 COMPANY OVERVIEW
  2. 8.2.2 COMPANY SNAPSHOT
  3. 8.2.3 OPERATING BUSINESS SEGMENTS
  4. 8.2.4 PRODUCT PORTFOLIO
  5. 8.2.5 BUSINESS PERFORMANCE
  6. 8.2.6 BUSINESS SEGMENTS
  7. 8.2.7 GEOGRAPHIC SEGMENTS
  8. 8.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.2.9 PRIMARY MARKET COMPETITORS
5. 8.3 B BRAUN
6. 1. 8.3.1 COMPANY OVERVIEW
  2. 8.3.2 COMPANY SNAPSHOT
  3. 8.3.3 OPERATING BUSINESS SEGMENTS
  4. 8.3.4 PRODUCT PORTFOLIO
  5. 8.3.5 BUSINESS PERFORMANCE
  6. 8.3.6 BUSINESS SEGMENTS
  7. 8.3.7 GEOGRAPHIC SEGMENTS
  8. 8.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.3.9 PRIMARY MARKET COMPETITORS
7. 8.4 NIPRO AUSTRALIA
8. 1. 8.4.1 COMPANY OVERVIEW
  2. 8.4.2 COMPANY SNAPSHOT
  3. 8.4.3 OPERATING BUSINESS SEGMENTS
  4. 8.4.4 PRODUCT PORTFOLIO
  5. 8.4.5 BUSINESS PERFORMANCE
  6. 8.4.6 BUSINESS SEGMENTS
  7. 8.4.7 GEOGRAPHIC SEGMENTS
  8. 8.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.4.9 PRIMARY MARKET COMPETITORS
9. 8.5 ASAHI KASEI CORPORATION
10. 1. 8.5.1 COMPANY OVERVIEW
  2. 8.5.2 COMPANY SNAPSHOT
  3. 8.5.3 OPERATING BUSINESS SEGMENTS
  4. 8.5.4 PRODUCT PORTFOLIO
  5. 8.5.5 BUSINESS PERFORMANCE
  6. 8.5.6 BUSINESS SEGMENTS
  7. 8.5.7 GEOGRAPHIC SEGMENTS
  8. 8.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.5.9 PRIMARY MARKET COMPETITORS
11. 8.6 BECTON, DICKINSON AND COMPANY
12. 1. 8.6.1 COMPANY OVERVIEW
  2. 8.6.2 COMPANY SNAPSHOT
  3. 8.6.3 OPERATING BUSINESS SEGMENTS
  4. 8.6.4 PRODUCT PORTFOLIO
  5. 8.6.5 BUSINESS PERFORMANCE
  6. 8.6.6 BUSINESS SEGMENTS
  7. 8.6.7 GEOGRAPHIC SEGMENTS
  8. 8.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.6.9 PRIMARY MARKET COMPETITORS
13. 8.7 TELEFLEX INCORPORATED
14. 1. 8.7.1 COMPANY OVERVIEW
  2. 8.7.2 COMPANY SNAPSHOT
  3. 8.7.3 OPERATING BUSINESS SEGMENTS
  4. 8.7.4 PRODUCT PORTFOLIO
  5. 8.7.5 BUSINESS PERFORMANCE
  6. 8.7.6 BUSINESS SEGMENTS
  7. 8.7.7 GEOGRAPHIC SEGMENTS
  8. 8.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.7.9 PRIMARY MARKET COMPETITORS
15. 8.8 MERIT MEDICAL SYSTEMS
16. 1. 8.8.1 COMPANY OVERVIEW
  2. 8.8.2 COMPANY SNAPSHOT
  3. 8.8.3 OPERATING BUSINESS SEGMENTS
  4. 8.8.4 PRODUCT PORTFOLIO
  5. 8.8.5 BUSINESS PERFORMANCE
  6. 8.8.6 BUSINESS SEGMENTS
  7. 8.8.7 GEOGRAPHIC SEGMENTS
  8. 8.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.8.9 PRIMARY MARKET COMPETITORS
17. 8.9 TEK EQUIPMENT
18. 1. 8.9.1 COMPANY OVERVIEW
  2. 8.9.2 COMPANY SNAPSHOT
  3. 8.9.3 OPERATING BUSINESS SEGMENTS
  4. 8.9.4 PRODUCT PORTFOLIO
  5. 8.9.5 BUSINESS PERFORMANCE
  6. 8.9.6 BUSINESS SEGMENTS
  7. 8.9.7 GEOGRAPHIC SEGMENTS
  8. 8.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.9.9 PRIMARY MARKET COMPETITORS
19. 8.10 ITL BIOMEDICAL
20. 1. 8.10.1 COMPANY OVERVIEW
  2. 8.10.2 COMPANY SNAPSHOT
  3. 8.10.3 OPERATING BUSINESS SEGMENTS
  4. 8.10.4 PRODUCT PORTFOLIO
  5. 8.10.5 BUSINESS PERFORMANCE
  6. 8.10.6 BUSINESS SEGMENTS
  7. 8.10.7 GEOGRAPHIC SEGMENTS
  8. 8.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 8.10.9 PRIMARY MARKET COMPETITORS

TABLE 1. AUSTRALIA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 2. HEMODIALYSIS (HD), MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 3. HEMODIALYSIS MACHINES, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 4. WATER TREATMENT SYSTEMS, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 5. ANCILLARY/OTHER HD EQUIPMENT, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 6. HD CONSUMABLES AND SUPPLIES, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 7. HD AFTERMARKET SERVICES, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 8. PERITONEAL DIALYSIS (PD), MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 9. PD CYCLERS / AUTOMATED PD MACHINES, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 10. ANCILLARY PD EQUIPMENT, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 11. PD CONSUMABLES AND SUPPLIES, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 12. PD AFTERMARKET SERVICES, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 13. AUSTRALIA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 14. HOSPITALS, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 15. DIALYSIS CENTERS, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 16. HOMECARE, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 17. AMBULATORY SURGICAL CENTERS, MARKET VALUE, 2024-2030, (BILLION USD)
TABLE 18. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT
TABLE 19. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS
TABLE 20. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 21. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 22. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 23. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY
TABLE 24. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 25. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS
TABLE 26. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 27. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 28. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 29. BAXTER INTERNATIONAL INC.: KEY STRATERGY
TABLE 30. B BRAUN: COMPANY SNAPSHOT
TABLE 31. B BRAUN: OPERATING BUSINESS SEGMENTS
TABLE 32. B BRAUN: PRODUCT PORTFOLIO
TABLE 33. B BRAUN: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 34. B BRAUN: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 35. B BRAUN: KEY STRATERGY
TABLE 36. NIPRO AUSTRALIA: COMPANY SNAPSHOT
TABLE 37. NIPRO AUSTRALIA: OPERATING BUSINESS SEGMENTS
TABLE 38. NIPRO AUSTRALIA: PRODUCT PORTFOLIO
TABLE 39. NIPRO AUSTRALIA: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 40. NIPRO AUSTRALIA: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 41. NIPRO AUSTRALIA: KEY STRATERGY
TABLE 42. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
TABLE 43. ASAHI KASEI CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 44. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO
TABLE 45. ASAHI KASEI CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 46. ASAHI KASEI CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 47. ASAHI KASEI CORPORATION: KEY STRATERGY
TABLE 48. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 49. BECTON, DICKINSON AND COMPANY: OPERATING BUSINESS SEGMENTS
TABLE 50. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 51. BECTON, DICKINSON AND COMPANY: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 52. BECTON, DICKINSON AND COMPANY: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 53. BECTON, DICKINSON AND COMPANY: KEY STRATERGY
TABLE 54. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 55. TELEFLEX INCORPORATED: OPERATING BUSINESS SEGMENTS
TABLE 56. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 57. TELEFLEX INCORPORATED: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 58. TELEFLEX INCORPORATED: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 59. TELEFLEX INCORPORATED: KEY STRATERGY
TABLE 60. MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
TABLE 61. MERIT MEDICAL SYSTEMS: OPERATING BUSINESS SEGMENTS
TABLE 62. MERIT MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 63. MERIT MEDICAL SYSTEMS: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 64. MERIT MEDICAL SYSTEMS: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 65. MERIT MEDICAL SYSTEMS: KEY STRATERGY
TABLE 66. TEK EQUIPMENT: COMPANY SNAPSHOT
TABLE 67. TEK EQUIPMENT: OPERATING BUSINESS SEGMENTS
TABLE 68. TEK EQUIPMENT: PRODUCT PORTFOLIO
TABLE 69. TEK EQUIPMENT: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 70. TEK EQUIPMENT: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 71. TEK EQUIPMENT: KEY STRATERGY
TABLE 72. ITL BIOMEDICAL: COMPANY SNAPSHOT
TABLE 73. ITL BIOMEDICAL: OPERATING BUSINESS SEGMENTS
TABLE 74. ITL BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 75. ITL BIOMEDICAL: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 76. ITL BIOMEDICAL: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 77. ITL BIOMEDICAL: KEY STRATERGY

FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. AUSTRALIA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
FIGURE 7. HEMODIALYSIS (HD), MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 8. HEMODIALYSIS MACHINES, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 9. WATER TREATMENT SYSTEMS, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 10. ANCILLARY/OTHER HD EQUIPMENT, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 11. HD CONSUMABLES AND SUPPLIES, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 12. HD AFTERMARKET SERVICES, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 13. PERITONEAL DIALYSIS (PD), MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 14. PD CYCLERS / AUTOMATED PD MACHINES, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 15. ANCILLARY PD EQUIPMENT, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 16. PD CONSUMABLES AND SUPPLIES, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 17. PD AFTERMARKET SERVICES, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 18. AUSTRALIA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
FIGURE 19. HOSPITALS, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 20. DIALYSIS CENTERS, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 21. HOMECARE, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 22. AMBULATORY SURGICAL CENTERS, MARKET VALUE, 2024-2030, (BILLION USD)
FIGURE 23. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2022-2024)
FIGURE 24. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS
FIGURE 25. BAXTER INTERNATIONAL INC.: NET SALES, (2022-2024)
FIGURE 26. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS
FIGURE 27. B BRAUN: NET SALES, (2022-2024)
FIGURE 28. B BRAUN: PRIMARY MARKET COMPETITORS
FIGURE 29. NIPRO AUSTRALIA: NET SALES, (2022-2024)
FIGURE 30. NIPRO AUSTRALIA: PRIMARY MARKET COMPETITORS
FIGURE 31. ASAHI KASEI CORPORATION: NET SALES, (2022-2024)
FIGURE 32. ASAHI KASEI CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 33. BECTON, DICKINSON AND COMPANY: NET SALES, (2022-2024)
FIGURE 34. BECTON, DICKINSON AND COMPANY: PRIMARY MARKET COMPETITORS
FIGURE 35. TELEFLEX INCORPORATED: NET SALES, (2022-2024)
FIGURE 36. TELEFLEX INCORPORATED: PRIMARY MARKET COMPETITORS
FIGURE 37. MERIT MEDICAL SYSTEMS: NET SALES, (2022-2024)
FIGURE 38. MERIT MEDICAL SYSTEMS: PRIMARY MARKET COMPETITORS
FIGURE 39. TEK EQUIPMENT: NET SALES, (2022-2024)
FIGURE 40. TEK EQUIPMENT: PRIMARY MARKET COMPETITORS
FIGURE 41. ITL BIOMEDICAL: NET SALES, (2022-2024)
FIGURE 42. ITL BIOMEDICAL: PRIMARY MARKET COMPETITORS

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.

Frequently Asked Questions

The leading companies in Australia dialysis market include Fresenius Medical Care AG And Co. KGaA, Baxter International Inc., B Braun, Nipro Australia, Asahi Kasei Corporation, Becton, Dickinson and Company, Teleflex Incorporated, Merit Medical Systems, Tek Equipment, ITL BioMedical, and others.

According to projections from Next Move Strategy Consulting, the Australia dialysis market is anticipated to reach USD 0.84 billion by 2030.

The significant challenges in the Australia dialysis market is the inherent risk of infections and complications associated with the procedure.

Australia dialysis market is segmented on the basis of dialysis type, products and services, and end-user.

The Australia dialysis market was valued at USD 0.60 billion in 2023, as per the findings of Next Move Strategy Consulting's report.

Download Free Sample

Phone Number *

Please enter Country Code and Phone No

Yes, I have read the Privacy Policy

Multi User

$2,575

Single User

$1,575

Enterprise

$3,875

Datapack

$1,975

Download Sample

Inquire Before Buying

Speak to Our Analyst

Share with Peers

About the Author

Sikha Haritwal is a researcher with more than 5 years of experience. She has been keeping a close eye on several industry verticals, including construction & manufacturing, personal care products, and consumer electronics. She has avid interest in writing news articles and hopes to use blog as a platform to share her knowledge with others.

About the Reviewer

Supradip Baul is the CEO and Founder of Next Move Strategy Consulting, driving the firm’s mission to provide data-driven insights and strategic intelligence. With extensive experience in market research and consulting, he has helped global organizations make informed decisions and achieve sustainable growth.

Request Sample

Phone Number *

Please enter Phone No

Please Select Country